ions.bio
Private Company
Funding information not available
Overview
ions.bio is a Munich-based biomarker solutions company offering a full-stack service from clinical sample collection to AI-powered data analysis. The company's core strength lies in its integrated platform combining automated laboratory processes, mass spectrometry-based proteomics/lipidomics/metabolomics, and proprietary bioinformatics software to de-risk and accelerate biomarker development. With a scientifically prolific founding team and a focus on generating validated, assay-ready biomarkers, ions.bio positions itself as a strategic partner for pharmaceutical and diagnostic companies seeking to leverage next-generation biomarkers.
Technology Platform
Integrated biomarker discovery platform combining clinical sample collection, mass spectrometry-based multi-omics (proteomics, lipidomics, metabolomics), and proprietary AI-driven data analysis/ bioinformatics software with a proprietary sample database.
Opportunities
Risk Factors
Competitive Landscape
ions.bio competes with large, diversified contract research organizations (CROs like LabCorp, IQVIA) that offer omics services, specialized proteomics/metabolomics service providers, and diagnostic companies with internal discovery platforms. Its differentiation lies in its end-to-end integration, proprietary AI software, strong focus on sample quality and validation, and the deep academic expertise of its founding team.